Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with

Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar...

Related Keywords

Switzerland ,Zurich ,Züsz ,Denmark ,Hvidovre ,Hovedstaden ,Copenhagen ,Køavn ,Swiss ,Dennis Fink ,Sanja Baumann Tomovska ,Oliverr Baumann ,Clinical Research Department ,Swiss Exchange ,University Hospital Basel ,Stock Exchange ,Hvidovre University Hospital ,Letter Of Intent Partnership ,Xlife Sciences ,Xlife Sciences Ag Key ,Quant Biomarkers ,Shareholders Meeting ,Year Report ,